<p><h1>Lung Surfactants Market Share & Market New Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030</h1></p><p><strong>Lung Surfactants Market Analysis and Latest Trends</strong></p>
<p><p>Lung surfactants are substances produced naturally in the lungs that help in the easy expansion of air sacs, also known as alveoli. These surfactants lower the surface tension within the alveoli, preventing them from collapsing and making it easier for the lungs to inflate and deflate. Lung surfactants play a crucial role in maintaining lung functionality and preventing respiratory distress in premature infants and individuals with lung conditions such as acute respiratory distress syndrome (ARDS).</p><p>The lung surfactants market is expected to witness significant growth in the coming years. The increasing prevalence of respiratory diseases such as ARDS, chronic obstructive pulmonary disease (COPD), and neonatal respiratory distress syndrome is driving the demand for lung surfactant therapies. Furthermore, rising premature births and advancements in neonatal care will also contribute to market growth.</p><p>The market is witnessing several trends that are shaping its landscape. One such trend is the growing preference for synthetic surfactants over natural surfactants, as synthetic surfactants have shown better efficacy and safety profiles in treating respiratory disorders. Additionally, the increasing adoption of minimally invasive techniques for surfactant administration and the development of novel surfactant formulations are further driving market growth.</p><p>Geographically, North America is expected to dominate the lung surfactants market, owing to the high prevalence of respiratory diseases and well-established healthcare infrastructure. Europe is also anticipated to witness significant growth due to the increasing elderly population and rising respiratory disorders. Furthermore, the Asia Pacific region is projected to experience rapid market growth due to the growing healthcare expenditure, increasing awareness about respiratory disorders, and improving neonatal care facilities.</p><p>In conclusion, the lung surfactants market is forecasted to grow at a CAGR of 7.8% during the forecast period. Factors such as the rise in respiratory diseases and premature births, along with advancements in surfactant formulations and administration techniques, are expected to drive market growth. The market's geographical dominance lies in North America, followed by Europe and the Asia Pacific.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1710831">https://www.reliableresearchreports.com/enquiry/request-sample/1710831</a></strong></p>
<p>&nbsp;</p>
<p><strong>Lung Surfactants Major Market Players</strong></p>
<p><p>The lung surfactants market is highly competitive, and several key players dominate the industry. Some of the major companies operating in this market include Chiesi Farmaceutici, Lyomark Pharma, AbbVie, ONY Biotech, Aviva Systems Biology Corporation, and Windtree Therapeutics. Below are detailed profiles of a few of these companies, along with information about their past history, market growth, market size, and sales revenue.</p><p>Chiesi Farmaceutici is a leading global pharmaceutical company headquartered in Italy. Established in 1935, the company has a rich history of more than 80 years. Chiesi specializes in the research, development, production, and marketing of innovative drugs, with a particular focus on respiratory medicine. Their lung surfactants portfolio includes products like Curosurf and Survanta. Chiesi has experienced significant market growth due to its commitment to clinical excellence and its global presence. The company has a strong position in the lung surfactants market, and its revenue in 2020 was approximately $2 billion.</p><p>Lyomark Pharma, a subsidiary of Martindale Pharma, is a UK-based pharmaceutical company that specializes in the development and commercialization of injectable drugs. Lyomark offers a range of lung surfactants products, including Alveofact. The company has a history of more than 40 years and is recognized for its expertise in lyophilization. Lyomark Pharma has witnessed steady market growth and has successfully established its presence in the lung surfactants market. However, sales revenue data for the company is not publicly available.</p><p>AbbVie is a global biopharmaceutical company that operates in multiple therapeutic areas, including respiratory care. While AbbVie is mainly known for its expertise in immunology, it also has a presence in the lung surfactants market through its product Survanta. AbbVie's lung surfactants business has experienced moderate growth, supported by the company's strong research and development capabilities. In 2020, AbbVie generated approximately $45 billion in sales revenue from its various pharmaceutical products, but the specific revenue generated from the lung surfactants market is not disclosed.</p><p>Overall, the lung surfactants market is characterized by intense competition among key players such as Chiesi Farmaceutici, Lyomark Pharma, AbbVie, ONY Biotech, Aviva Systems Biology Corporation, and Windtree Therapeutics. These companies have witnessed varying levels of market growth and have varying market sizes. While Chiesi Farmaceutici and AbbVie have disclosed their sales revenue, the revenue figures for other companies are not publicly available.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Lung Surfactants Manufacturers?</strong></p>
<p><p>The lung surfactants market is witnessing significant growth due to increasing prevalence of respiratory diseases such as acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD). Surfactants help in reducing surface tension in the lungs, improving lung function and preventing lung collapse. The market is expected to be driven by advancements in technology, rising healthcare spending, and a growing geriatric population. Additionally, the increasing number of premature births and the need for surfactant replacement therapy in neonates will further boost market growth. Overall, the lung surfactants market is projected to experience steady growth in the future with ample opportunities for key players.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1710831">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1710831</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Lung Surfactants Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Intratracheal</li><li>Injectable</li></ul></p>
<p><p>Lung surfactants are substances used to treat respiratory distress syndrome in premature infants. There are two types of lung surfactants available in the market: intratracheal and injectable. Intratracheal surfactants are directly administered into the infant's lungs through a tube inserted in their airway, while injectable surfactants are delivered systemically through injections. Both types aim to improve lung functionality and reduce surface tension, allowing easier expansion of the lungs and preventing the collapse of small air sacs. These surfactants play a crucial role in the treatment of respiratory distress syndrome in neonates.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1710831">https://www.reliableresearchreports.com/purchase/1710831</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Lung Surfactants Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospital</li><li>Special Clinic</li><li>Recovery Center</li></ul></p>
<p><p>Lung surfactants find primary application in the healthcare industry. They are extensively used in hospitals, special clinics, and recovery centers. Hospitals are equipped with the necessary facilities to provide critical care to patients with lung-related disorders. Special clinics cater to specific respiratory conditions, providing specialized treatments and therapies. Recovery centers focus on rehabilitation and recuperation, assisting patients in their journey towards lung function improvement. These healthcare settings play a crucial role in diagnosing, managing, and treating various respiratory diseases, where lung surfactants are employed to support effective lung function.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Lung Surfactants Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The global lung surfactants market is expected to witness significant growth across various regions, including North America (NA), Asia-Pacific (APAC), Europe, United States of America (USA), and China. North America is projected to dominate the market due to the presence of advanced healthcare facilities, favorable government initiatives, and rising prevalence of respiratory disorders. Similarly, Europe is expected to hold a substantial market share owing to the increasing geriatric population and high healthcare expenditure. Meanwhile, China is anticipated to witness rapid growth, primarily driven by the expanding population, rising healthcare awareness, and improving healthcare infrastructure. These regions are likely to contribute a significant market share percentage valuation, with North America and Europe leading the way.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1710831">https://www.reliableresearchreports.com/purchase/1710831</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1710831">https://www.reliableresearchreports.com/enquiry/request-sample/1710831</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@ebbakautzer/electric-actuated-butterfly-valve-market-trends-and-market-analysis-forecasted-for-period-2023-2030-028078e9613b">Electric Actuated Butterfly Valve Market</a></p><p><a href="https://www.linkedin.com/pulse/decoding-strontium-oxide-market-deep-dive-latest-trends-8urae/">Strontium Oxide Market</a></p><p><a href="https://medium.com/@madelynhowe/steam-valves-market-competitive-analysis-market-trends-and-forecast-to-2030-6d3944e6639b">Steam Valves Market</a></p><p><a href="https://github.com/scarol104/Market-Research-Report-List-1/blob/main/combination-poly-alpha-olefin-market.md">Combination Poly Alpha Olefin Market</a></p><p><a href="https://www.linkedin.com/pulse/strontium-perchlorate-market-insights-players-forecast-till-dtf0e/">Strontium Perchlorate Market</a></p></p>